找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Management of Pancreatic Neuroendocrine Tumors; Joseph R. Pisegna Book 2015 Springer Science+Business Media New York 2015 EGF receptor.ang

[复制链接]
查看: 38212|回复: 47
发表于 2025-3-21 18:18:51 | 显示全部楼层 |阅读模式
书目名称Management of Pancreatic Neuroendocrine Tumors
编辑Joseph R. Pisegna
视频video
概述Provides a multidisciplinary approach.Written by international experts in their particular fields.A comprehensive review of the most recent developments.Includes supplementary material:
图书封面Titlebook: Management of Pancreatic Neuroendocrine Tumors;  Joseph R. Pisegna Book 2015 Springer Science+Business Media New York 2015 EGF receptor.ang
描述.This book provides the reader with a multidisciplinary approach that is state of the art and reflects input from the European Neuroendocrine Tumor Society and the North American Neuroendocrine Tumor Society. In particular, the text focuses on the pathophysiology of neuroendocrine tumors and includes a comprehensive review of the most recent developments in understanding the complex hormone and receptor signaling that is important for the future development of potent pharmacological treatments. The volume reviews the pathological grading and staging systems providing useful clinical information for the treating clinician as well as a useful reference for pathologists. The clinical management of neuroendocrine tumors is reviewed enabling the treating physician to understand the diagnostic approaches to differentiating the various types of neuroendocrine tumors. In addition, the treatments are reviewed in great detail and include novel radiological, surgical, and chemotherapeutic approaches. .The reader will utilize this book as both a comprehensive and quick reference guide through the use of diagnostic and treatment algorithms. Written by international experts in their particular f
出版日期Book 2015
关键词EGF receptor; angiography; endocrine neoplasia; endoscopic ultrasonography; zollinger ellison syndrome; D
版次1
doihttps://doi.org/10.1007/978-1-4939-1798-3
isbn_softcover978-1-4939-4663-1
isbn_ebook978-1-4939-1798-3
copyrightSpringer Science+Business Media New York 2015
The information of publication is updating

书目名称Management of Pancreatic Neuroendocrine Tumors影响因子(影响力)




书目名称Management of Pancreatic Neuroendocrine Tumors影响因子(影响力)学科排名




书目名称Management of Pancreatic Neuroendocrine Tumors网络公开度




书目名称Management of Pancreatic Neuroendocrine Tumors网络公开度学科排名




书目名称Management of Pancreatic Neuroendocrine Tumors被引频次




书目名称Management of Pancreatic Neuroendocrine Tumors被引频次学科排名




书目名称Management of Pancreatic Neuroendocrine Tumors年度引用




书目名称Management of Pancreatic Neuroendocrine Tumors年度引用学科排名




书目名称Management of Pancreatic Neuroendocrine Tumors读者反馈




书目名称Management of Pancreatic Neuroendocrine Tumors读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-22 00:02:01 | 显示全部楼层
发表于 2025-3-22 03:45:45 | 显示全部楼层
发表于 2025-3-22 08:31:45 | 显示全部楼层
发表于 2025-3-22 10:10:37 | 显示全部楼层
发表于 2025-3-22 15:17:17 | 显示全部楼层
Pathology of Pancreatic Neuroendocrine Tumors,lassification tumors (AJCC 2010). Accordingly, the pathological evaluation of pancreatic neuroendocrine neoplasms is focused on grade and stage, while functional status should only be supplemented if a clinical syndrome is recognized.
发表于 2025-3-22 18:18:29 | 显示全部楼层
发表于 2025-3-22 23:39:45 | 显示全部楼层
Laboratory Assessment of NETs, biomarkers in functioning pNETs, whereas Chromogranin-A (CgA) is the only established non-specific (general) biomarker for all NETs. Several factors need to be taken into account when interpreting CgA levels, as certain drugs or clinical entities may be associated with its increased levels. The rol
发表于 2025-3-23 04:10:42 | 显示全部楼层
发表于 2025-3-23 09:33:28 | 显示全部楼层
Nuclear Medicine Approaches to Treatment of Neuroendocrine Tumors,o PRRT, locoregional therapies such as selective internal radiation therapy (SIRT) can be performed in case of liver-dominant metastasis in addition to PRRT..Currently ongoing trials investigate whether individual dosimetry-derived personalized “high-dose” approaches allow for patient-tailored treat
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-16 01:55
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表